Short Hills, NJ, United States of America

Prajwal Gunwanth Thool

This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Celgene Corporation. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Prajwal Gunwanth Thool. Retrieved from https://idiyas.com/inventor/prajwal-gunwanth-thool

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Prajwal Gunwanth Thool: Innovator in Pharmaceutical Compositions

Introduction

Prajwal Gunwanth Thool is a notable inventor based in Short Hills, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions and methods.

Latest Patents

Prajwal holds 3 patents that focus on pharmaceutical compositions. His latest patents include formulations comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile. These patents detail methods of preparing and using these pharmaceutical compositions, which are designed for oral dosage formulations.

Career Highlights

Prajwal is currently employed at Celgene Corporation, where he continues to advance his research and development efforts in the pharmaceutical industry. His work is characterized by a commitment to innovation and improving therapeutic options.

Collaborations

Prajwal collaborates with talented professionals in his field, including Anjali Agrawal and Ming J Chen. These collaborations enhance the research and development process, leading to more effective pharmaceutical solutions.

Conclusion

Prajwal Gunwanth Thool is a distinguished inventor whose work in pharmaceutical compositions is paving the way for advancements in medicine. His contributions are vital to the ongoing evolution of therapeutic formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…